Recombinant DNA technology has profoundly advanced virtually every aspect of biological and medical sciences, from basic research to biotechnology. Here, I discuss conceptual connections linking fundamental discoveries that were enabled by the technology, advances in the understanding of gene regulation in both prokaryotes and eukaryotes, and the recent FDA-approved CRISPR-based gene therapy for sickle cell anemia and β-thalassemia based on transcriptional derepression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cell.2024.10.037 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!